Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

USA - NYSEARCA:EMX - CA26873J1075 - Common Stock

4.79 USD
+0.2 (+4.36%)
Last: 9/26/2025, 8:04:00 PM
4.91 USD
+0.12 (+2.51%)
Pre-Market: 9/29/2025, 4:00:06 AM
Fundamental Rating

5

Overall EMX gets a fundamental rating of 5 out of 10. We evaluated EMX against 156 industry peers in the Metals & Mining industry. EMX has a great financial health rating, but its profitability evaluates not so good. EMX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EMX had positive earnings in the past year.
EMX had a positive operating cash flow in the past year.
EMX had negative earnings in 4 of the past 5 years.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.31%, EMX is in the better half of the industry, outperforming 70.51% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.19%, EMX is in the better half of the industry, outperforming 64.74% of the companies in the same industry.
EMX has a Return On Invested Capital (2.64%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROIC 2.64%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

EMX has a Profit Margin of 16.28%. This is amongst the best in the industry. EMX outperforms 82.05% of its industry peers.
EMX has a better Operating Margin (15.92%) than 69.87% of its industry peers.
Industry RankSector Rank
OM 15.92%
PM (TTM) 16.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMX is destroying value.
The number of shares outstanding for EMX has been reduced compared to 1 year ago.
The number of shares outstanding for EMX has been increased compared to 5 years ago.
Compared to 1 year ago, EMX has a worse debt to assets ratio.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 14.36 indicates that EMX is not in any danger for bankruptcy at the moment.
EMX's Altman-Z score of 14.36 is amongst the best of the industry. EMX outperforms 81.41% of its industry peers.
EMX has a debt to FCF ratio of 8.95. This is a slightly negative value and a sign of low solvency as EMX would need 8.95 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 8.95, EMX is doing good in the industry, outperforming 64.10% of the companies in the same industry.
EMX has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
EMX's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. EMX outperforms 48.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.95
Altman-Z 14.36
ROIC/WACC0.3
WACC8.7%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 7.86 indicates that EMX has no problem at all paying its short term obligations.
EMX has a better Current ratio (7.86) than 87.82% of its industry peers.
EMX has a Quick Ratio of 7.86. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX's Quick ratio of 7.86 is amongst the best of the industry. EMX outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 7.86
Quick Ratio 7.86
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

EMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 305.16%, which is quite impressive.
EMX shows a decrease in Revenue. In the last year, the revenue decreased by -8.72%.
EMX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.11% yearly.
EPS 1Y (TTM)305.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 71.00% on average per year.
EMX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.78% yearly.
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 159.67, the valuation of EMX can be described as expensive.
EMX's Price/Earnings ratio is in line with the industry average.
EMX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
EMX is valuated quite expensively with a Price/Forward Earnings ratio of 108.11.
The rest of the industry has a similar Price/Forward Earnings ratio as EMX.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, EMX is valued quite expensively.
Industry RankSector Rank
PE 159.67
Fwd PE 108.11
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

EMX's Enterprise Value to EBITDA ratio is in line with the industry average.
EMX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 265.25
EV/EBITDA 66.8
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

EMX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EMX's earnings are expected to grow with 71.00% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y71%

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

NYSEARCA:EMX (9/26/2025, 8:04:00 PM)

Premarket: 4.91 +0.12 (+2.51%)

4.79

+0.2 (+4.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners22.14%
Inst Owner Change50.29%
Ins Owners14.94%
Ins Owner ChangeN/A
Market Cap522.97M
Analysts84.44
Price Target4.26 (-11.06%)
Short Float %0.09%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.51%
Min EPS beat(2)35.92%
Max EPS beat(2)197.09%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)25.42%
Valuation
Industry RankSector Rank
PE 159.67
Fwd PE 108.11
P/S 24.43
P/FCF 265.25
P/OCF 50.35
P/B 6.29
P/tB 6.29
EV/EBITDA 66.8
EPS(TTM)0.03
EY0.63%
EPS(NY)0.04
Fwd EY0.93%
FCF(TTM)0.02
FCFY0.38%
OCF(TTM)0.1
OCFY1.99%
SpS0.2
BVpS0.76
TBVpS0.76
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROCE 3.34%
ROIC 2.64%
ROICexc 3.17%
ROICexgc 3.17%
OM 15.92%
PM (TTM) 16.28%
GM N/A
FCFM 9.21%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.95
Debt/EBITDA 2.27
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion 133.77%
Profit Quality 56.55%
Current Ratio 7.86
Quick Ratio 7.86
Altman-Z 14.36
F-Score7
WACC8.7%
ROIC/WACC0.3
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)305.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3417.07%
EBIT Next 3Y256.1%
EBIT Next 5YN/A
FCF growth 1Y179.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y622.77%
OCF growth 3YN/A
OCF growth 5YN/A